Ois Podcast

As president and CEO of LENTECHS, a clinical-stage ophthalmic device company on the verge of commercializing a new contact lens, Robin Sears applies the core competencies he learned while moving through the ranks at Johnson & Johnson and Allergan.As told to podcast host Paul Karpecki, OD, when Robin heard about the presbyopia lens developed by Melissa Bailey, OD, PhD, and Joe Barr, OD, he saw a tremendous opportunity to reshape the market. He started fundraising and turned a novel invention into a business.Because of the demand for a presbyopia lens, that business may soon take off. LENTECHS research showed 74% of presbyopes who wear glasses want a contact lens solution. Why aren’t they using one now? Visual compromise. Current lenses don’t resolve near, mid, and far vision well enough for this growing population.The LENTECHS lens, called APIOC™, is based on a new type of contact lens-wearing experience. The lens is suspended behind the upper eyelid, which allows the eye to move freely behind the stable c